# TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma

> **NCT01542931** · PHASE2,PHASE3 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 256 (actual)

## Conditions studied

- Stage III Oral Cavity Squamous Cell Carcinoma
- Stage IVA Oral Cavity Squamous Cell Carcinoma

## Interventions

- **DRUG:** TPF induction chemotherapy

## Key facts

- **NCT ID:** NCT01542931
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12-31
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2017-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01542931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01542931, "TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01542931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*